Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

NatWest names Solange Chamberlain as head of retail bank

(Sharecast News) - NatWest has named Solange Chamberlain as the head of its retail banking operation, replacing David Lindberg who announced his resignation six months ago. Chamberlain, currently the group director of strategic development, will be appointed as chief executive of the Retail Bank on 1 July, reporting directly into group CEO Paul Thwaite.

"I'm delighted to welcome Solange as the new CEO of Retail at such a pivotal time for NatWest," Thwaite said in a statement.

"She has a deep understanding of the competitive and fast-moving environment we're operating in and will help us accelerate our strategy. Her knowledge of our customers, sharp strategic thinking, and track record of transformation delivery will help us to grow our retail business and succeed with customers."

Chamberlain joined NatWest in 2019, having previously been chief operating officer of the bank's Commercial and Institutional business.

Before joining NatWest, she worked in senior roles at Lloyds Banking Group, and previously provided advisory services to financial institutions like Lazard, Citigroup and Perella Weinberg.

The announcement comes just three days after NatWest returned to private ownership, with the HM Treasury selling its remaining stake in the bank on Friday.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.